Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Incidence, Course and Outcome of Cellular and Antibody-mediated Rejection in Immunological High-risk Kidney Transplantation, a Prospective Cohort PROCARE2 Study

NCT05140018 is registered in ClinicalTrials.gov with University Medical Center Groningen as lead sponsor.

NCT NCT05140018
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05140018 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Incidence, Course and Outcome of Cellular and Antibody-mediated Rejection in Immunological High-risk Kidney Transplantation, a Prospective Cohort PROCARE2 Study
Lead sponsor
University Medical Center Groningen
Phase
Observational
Overall status
Unknown status
Start date
January 1, 2022
Completion date
March 1, 2026
Enrollment
225 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

antibody-mediated rejection, immunosuppression, kidney transplantation